| Application no. and date | 22734284.7 (espacenet) (Federated) (European Patent Register), 20220615 | | Patent/reg. no. and date | DK/EP 4355915, 20260204 | | Publication date | 20240424 | | Priority no. and date | EP 21305826, 20210616 | | EP pub. no. and date |
EP 4355915 20240424 | | Effective date | | | Applicant/owner | Genfit, 885 avenue Eugène Avinée
59120 Loos, FR | | Applicant ref. no. | | | Inventor | MAGNANENSI, Jérémy,
59800 Lille, FR,
HAJJI, Yacine,
59000 Lille, FR,
ROSENQUIST, Christian,
92200 Neuilly-sur-Seine, FR,
HOSMANE, Suneil,
Arlington, MA 02474, US | | Representative | | | Opponent | | | IPC Class | A61P 1/16 (2006.01) , C12Q 1/6883 (2018.01) | | Title | METHOD FOR NASH RISK ASSESSMENT IN PATIENTS HAVING A METABOLIC DISORDER | | Int. application no. | EP2022066410 | | Int. publication no. | WO2022263565 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
